Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer's and Diabetic Diseases

Molecules. 2024 Feb 5;29(3):740. doi: 10.3390/molecules29030740.

Abstract

The molecular events of protein misfolding and self-aggregation of tau and amylin are associated with the progression of Alzheimer's and diabetes, respectively. Recent studies suggest that tau and amylin can form hetero-tau-amylin oligomers. Those hetero-oligomers are more neurotoxic than homo-tau oligomers. So far, the detailed interactions between the hetero-oligomers and the neuronal membrane are unknown. Using multiscale MD simulations, the lipid binding and protein folding behaviors of hetero-oligomers on asymmetric lipid nanodomains or raft membranes were examined. Our raft membranes contain phase-separated phosphatidylcholine (PC), cholesterol, and anionic phosphatidylserine (PS) or ganglioside (GM1) in one leaflet of the lipid bilayer. The hetero-oligomers bound more strongly to the PS and GM1 than other lipids via the hydrophobic and hydrophilic interactions, respectively, in the raft membranes. The hetero-tetramer disrupted the acyl chain orders of both PC and PS in the PS-containing raft membrane, but only the GM1 in the GM1-containing raft membrane as effectively as the homo-tau-tetramer. We discovered that the alpha-helical content in the heterodimer was greater than the sum of alpha-helical contents from isolated tau and amylin monomers on both raft membranes, indicative of a synergetic effect of tau-amylin interactions in surface-induced protein folding. Our results provide new molecular insights into understanding the cross-talk between Alzheimer's and diabetes.

Keywords: Alzheimer’s and diabetics crosstalk; amyloid-raft structures; anionic lipid nanodomains; lipid raft; neuronal membrane leaflets; oligomers; protein folding; protein-lipid binding.

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides / metabolism
  • Diabetes Mellitus*
  • G(M1) Ganglioside / chemistry
  • Humans
  • Islet Amyloid Polypeptide / chemistry
  • Lipid Bilayers / chemistry
  • Phosphatidylcholines

Substances

  • Islet Amyloid Polypeptide
  • Amyloid beta-Peptides
  • G(M1) Ganglioside
  • Lipid Bilayers
  • Phosphatidylcholines

Grants and funding

This research was funded by the Robert A. Welch Foundation Grant W-2057-20210327, the National Science Foundation [OAC 1531594], the National Institutes of Health [RC1-GM090897], and the Williams Endowment of Interdisciplinary Physics at Trinity University.